(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PAR FORMULATIONS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

PAR FORMULATIONS

ST13

US500000085681233

Class

35, 40, 42

Filing

85681233

Registration

4647341

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

60

Latest update

01/27/2026

Classification

Registered

Trademark type

Word

Nice classes

35, 40, 42

Filing date

07/19/2012

Registration date

12/02/2014

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/14/2024

Last transaction

01/27/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

03/26/2012

First use in commerce

03/26/2012

Drawing code

4

Owner type

03

Owner location

Woodcliff Lake, NJ

Examiner

SHANAHAN, PATRICK

Law office

M70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

PAR PHARMACEUTICAL COMPANIES, INC.
PH HEALTH LIMITED
ENDO OPERATIONS LIMITED
ENDO OPERATIONS LIMITED
PAR PHARMACEUTICAL, INC.

Representatives

Camille M. Miller Cozen O'Connor

Technical classification

Nice Classes

Class 35Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Outsourcing in the field of pharmaceuticals

Class 40

Manufacture of and development of pharmaceutical products to order and/or specification of others; Providing technical information in the field of pharmaceutical manufacturing

Class 42

Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services

Publications

History of USPTO decisions and trademark events.

60 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/26/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/02/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/14/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/04/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/16/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/28/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/01/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/14/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/14/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/14/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/14/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

12/05/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/02/2023

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/22/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/04/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/04/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

12/01/2020

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

11/19/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/07/2020

E815

TEAS SECTION 8 & 15 RECEIVED

12/11/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/02/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/11/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/11/2017

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/26/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/08/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/08/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/04/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/04/2016

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/07/2015

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/30/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/20/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

12/02/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/16/2014

PUBO

PUBLISHED FOR OPPOSITION

09/16/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/27/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/13/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/05/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/04/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/04/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/04/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/07/2014

GNRT

NON-FINAL ACTION E-MAILED

02/07/2014

CNRT

NON-FINAL ACTION WRITTEN

02/07/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/13/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/13/2014

ALIE

ASSIGNED TO LIE

01/06/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/09/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/07/2013

GNRT

NON-FINAL ACTION E-MAILED

06/07/2013

CNRT

NON-FINAL ACTION WRITTEN

06/07/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/15/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/14/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/14/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/14/2012

GNRT

NON-FINAL ACTION E-MAILED

11/14/2012

CNRT

NON-FINAL ACTION WRITTEN

11/14/2012

DOCK

ASSIGNED TO EXAMINER

11/14/2012

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/10/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/26/2012

NWAP

NEW APPLICATION ENTERED

07/23/2012

Continuous trademark protection

Get notified about every new filing that threatens PAR FORMULATIONS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.